Observational study of treatment for children with Burkitt lymphoma
Studies children with Burkitt lymphoma, a blood cancer, and how they respond to treatment.
Plain-language title generated from the registry record
Registry title: Recommendations for the Treatment of Children With Burkitt's Lymphoma
Key facts
- Where
- Bamako, MaliSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with Burkitt's lymphoma, a fast-growing cancer of the B cells, in any part of the body.
- Age
- Up to 18 years
- Sex
- All sexes can join.
- Disease stage
- Burkitt's lymphoma in any location, confirmed by cytology or histology.
- Earlier treatment
- The child must not have been treated before.
- Biomarker or test result
- The tumour must be a B cell tumour.
Main reasons for not taking part
- Tumour that is not a B cell tumour
- Child has been treated before
- Another illness that makes the treatment unsuitable
- Parents refuse
Read by machine on 12 November 2026.
Where in Mali
- CHU Gabriel Touré (HGT)Bamako, MaliContact: BOUBACAR TOGO, PROFESSEURTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- French Africa Pediatric Oncology Group
- Trial code
- NCT04425421
- Record updated
- 2 March 2026
- Original description
This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.Read full original descriptionShow less
Recommendations for the Treatment of Children With Burkitt's Lymphoma
This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.
Inclusion: Clinical diagnosis of Burkitt's Lymphoma: all location. Diagnosis by cytology or histology. Not possible to follow all the treatment; -.
Exclusion: Not a B Cell tumor. Child has been previously treated. Child has also another illness which would render the treatment incompatible. Parents refusal.